Neuroimmune Activation in Chronic Heart Failure

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 13, Iss. 1, 2013-03 ,pp. : 68-75

Bentham Science Publishers

Access to resources Recommend Favorite

Inhalation of diluted diesel engine emission impacts heart rate variability and arrhythmia occurrence in a rat model of chronic ischemic heart failure

By Anselme Frédéric   Loriot Stéphane   Henry Jean-Paul   Dionnet Frédéric   Napoleoni Jean-Gérard   Thuillez Christian   Morin Jean-Paul  

Archives of Toxicology, Vol. 81, Iss. 4, 2007-04 ,pp. : 299-307

Springer Publishing Company

Access to resources Recommend Favorite

Valsartan: In Chronic Heart Failure

By Wellington K.   Goa K.L.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 4, 2002-01 ,pp. : 267-274

Adis International

Access to resources Recommend Favorite

Chronic administration of amitriptyline and caffeine in a rat model of neuropathic pain: multiple interactions

By Esser M.J.   Chase T.   Allen G.V.   Sawynok J.  

European Journal of Pharmacology, Vol. 430, Iss. 2, 2001-11 ,pp. : 211-218

Elsevier

Access to resources Recommend Favorite

Effects of administration of iron isomaltoside 1000 in patients with chronic heart failure. A pilot study

By HILDEBRANDT PER R.   BRUUN NIELS E.   NIELSEN OLAV W.   PANTEV EMIL   SHIVA FARZAD   VIDEBÆK LARS   WIKSTRÖM GERHARD   THOMSEN LARS L.  

Transfusion Alternatives in Transfusion Medicine, Vol. 11, Iss. 4, 2010-12 ,pp. : 131-137

Blackwell Publishing

Access to resources Recommend Favorite